121 related articles for article (PubMed ID: 19194308)
1. Costs of providing care for HIV-infected adults in an urban HIV clinic in Soweto, South Africa.
Martinson N; Mohapi L; Bakos D; Gray GE; McIntyre JA; Holmes CB
J Acquir Immune Defic Syndr; 2009 Mar; 50(3):327-30. PubMed ID: 19194308
[TBL] [Abstract][Full Text] [Related]
2. Cost and resource use of patients on antiretroviral therapy in the urban and semiurban public sectors of South Africa.
Meyer-Rath G; Miners A; Santos AC; Variava E; Venter WD
J Acquir Immune Defic Syndr; 2012 Nov; 61(3):e25-32. PubMed ID: 22895437
[TBL] [Abstract][Full Text] [Related]
3. Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya.
Larson BA; Bii M; Halim N; Rohr JK; Sugut W; Sawe F
PLoS One; 2018; 13(8):e0200199. PubMed ID: 30096177
[TBL] [Abstract][Full Text] [Related]
4. Treatment Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic versus a Hospital-Based HIV Clinic in South Africa.
Long LC; Rosen SB; Brennan A; Moyo F; Sauls C; Evans D; Modi SL; Sanne I; Fox MP
PLoS One; 2016; 11(12):e0168118. PubMed ID: 27942005
[TBL] [Abstract][Full Text] [Related]
5. Patient costs incurred by people living with HIV/AIDS prior to ART initiation in primary healthcare facilities in Gauteng, South Africa.
Pillai N; Foster N; Hanifa Y; Ndlovu N; Fielding K; Churchyard G; Chihota V; Grant AD; Vassall A
PLoS One; 2019; 14(2):e0210622. PubMed ID: 30742623
[TBL] [Abstract][Full Text] [Related]
6. Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda.
Jain V; Chang W; Byonanebye DM; Owaraganise A; Twinomuhwezi E; Amanyire G; Black D; Marseille E; Kamya MR; Havlir DV; Kahn JG
PLoS One; 2015; 10(12):e0143433. PubMed ID: 26632823
[TBL] [Abstract][Full Text] [Related]
7. Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: a retrospective cohort study.
Scott CA; Iyer HS; McCoy K; Moyo C; Long L; Larson BA; Rosen S
BMC Public Health; 2014 Mar; 14():296. PubMed ID: 24684772
[TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of herpes simplex virus-2 suppressive therapy with daily aciclovir for delaying HIV disease progression among HIV-1-infected women in South Africa.
Vickerman P; Devine A; Foss AM; Delany-Moretlwe S; Mayaud P; Meyer-Rath G
Sex Transm Dis; 2011 May; 38(5):401-9. PubMed ID: 21317689
[TBL] [Abstract][Full Text] [Related]
9. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
Rosen S; Maskew M; Fox MP; Nyoni C; Mongwenyana C; Malete G; Sanne I; Bokaba D; Sauls C; Rohr J; Long L
PLoS Med; 2016 May; 13(5):e1002015. PubMed ID: 27163694
[TBL] [Abstract][Full Text] [Related]
10. Fast-track treatment initiation counselling in South Africa: A cost-outcomes analysis.
Larson BA; Pascoe SJS; Huber A; Long LC; Murphy J; Miot J; Fraser-Hurt N; Fox MP; Rosen S
PLoS One; 2021; 16(3):e0248551. PubMed ID: 33735206
[TBL] [Abstract][Full Text] [Related]
11. Comparative costs of inpatient care for HIV-infected and uninfected children and adults in Soweto, South Africa.
Thomas LS; Manning A; Holmes CB; Naidoo S; van der Linde F; Gray GE; Martinson NA
J Acquir Immune Defic Syndr; 2007 Dec; 46(4):410-6. PubMed ID: 17786130
[TBL] [Abstract][Full Text] [Related]
12. Initiating antiretroviral therapy for HIV at a patient's first clinic visit: a cost-effectiveness analysis of the rapid initiation of treatment randomized controlled trial.
Long LC; Maskew M; Brennan AT; Mongwenyana C; Nyoni C; Malete G; Sanne I; Fox MP; Rosen S
AIDS; 2017 Jul; 31(11):1611-1619. PubMed ID: 28463879
[TBL] [Abstract][Full Text] [Related]
13. Cost of a dedicated ART clinic.
Harling G; Bekker LG; Wood R
S Afr Med J; 2007 Aug; 97(8):593-6. PubMed ID: 17952216
[TBL] [Abstract][Full Text] [Related]
14. Can differentiated care models solve the crisis in HIV treatment financing? Analysis of prospects for 38 countries in sub-Saharan Africa.
Barker C; Dutta A; Klein K
J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21648. PubMed ID: 28770597
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with patterns of plural healthcare utilization among patients taking antiretroviral therapy in rural and urban South Africa: a cross-sectional study.
Moshabela M; Schneider H; Silal SP; Cleary SM
BMC Health Serv Res; 2012 Jul; 12():182. PubMed ID: 22747971
[TBL] [Abstract][Full Text] [Related]
16. One world, one hope: the cost of providing antiretroviral therapy to all nations.
Hogg RS; Weber AE; Craib KJ; Anis AH; O'Shaughnessy MV; Schechter MT; Montaner JS
AIDS; 1998 Nov; 12(16):2203-9. PubMed ID: 9833862
[TBL] [Abstract][Full Text] [Related]
17. Simplified clinical algorithm for identifying patients eligible for same-day HIV treatment initiation (SLATE): Results from an individually randomized trial in South Africa and Kenya.
Rosen S; Maskew M; Larson BA; Brennan AT; Tsikhutsu I; Fox MP; Vezi L; Bii M; Venter WDF
PLoS Med; 2019 Sep; 16(9):e1002912. PubMed ID: 31525187
[TBL] [Abstract][Full Text] [Related]
18. Cost and cost-effectiveness of transitioning to universal initiation of lifelong antiretroviral therapy for all HIV-positive pregnant and breastfeeding women in Swaziland.
Cunnama L; Abrams EJ; Myer L; Gachuhi A; Dlamini N; Hlophe T; Kikuvi J; Langwenya N; Mthethwa S; Mudonhi D; Nhlabatsi B; Nuwagaba-Biribonwoha H; Okello V; Sahabo R; Zerbe A; Sinanovic E
Trop Med Int Health; 2018 Sep; 23(9):950-959. PubMed ID: 29956426
[TBL] [Abstract][Full Text] [Related]
19. Comparative cost analysis of point-of-care versus laboratory-based testing to initiate and monitor HIV treatment in South Africa.
Simeon K; Sharma M; Dorward J; Naidoo J; Dlamini N; Moodley P; Samsunder N; Barnabas RV; Garrett N; Drain PK
PLoS One; 2019; 14(10):e0223669. PubMed ID: 31618220
[TBL] [Abstract][Full Text] [Related]
20. The costs of HIV treatment and care in Ghana.
Mikkelsen E; Hontelez JAC; Nonvignon J; Amon S; Asante FA; Aikins MK; van de Haterd J; Baltussen R
AIDS; 2017 Oct; 31(16):2279-2286. PubMed ID: 28991025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
